FPR2 and metabolic dysfunction-associated steatotic liver disease: In line with the human liver, these findings indicate that Fpr2 is highly expressed in the livers of healthy females and is downregulated with estrogen reduction and in the damaged liver, suggesting that distinct expression of Fpr2 in female mice might be associated with resistance to NAFLD-induced damage in women.